X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Acta Cardiologica Sinica

期刊標題檢索 ACTA CARDIOL SI 最新評論: This varies from person to person. If the main result has been complet... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Acta Cardiologica Sinica]您好,您是該頁面的第 20259 位訪客。

期刊簡介
期刊名稱Acta Cardiologica Sinica Acta Cardiologica Sinica
LetPub Score
3.8
50 ratings
Rate

Reputation
4.2

Influence
2.4

Speed
9.1

期刊簡稱ACTA CARDIOL SIN
ISSN1011-6842
h-index12
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.900.4110.651
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q3208 / 387

自引率 (2023-2024)22.20%自引率趨勢
掲載範囲
Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.
官方網站http://www.tsoc.org.tw/index.php?action=journal
在線稿件提交http://www.tsoc.org.tw/index.php?action=journal&do=page&cid=1&id=58
開放訪問No
出版商Republic of China Society of Cardiology
主題領域医学
出版國/地區TAIWAN
發行頻率四半期刊行
創刊年1985
每年文章數60每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ3128/220
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1011-6842%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Acta Cardiologica Sinica】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews CardiologyH-index: 105

    CiteScore: 53.10
    EUROPEAN HEART JOURNALH-index: 265

    CiteScore: 39.30
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYH-index: 394

    CiteScore: 42.70
    EUROPEAN JOURNAL OF HEART FAILUREH-index: 119

    CiteScore: 27.30
    CARDIOVASCULAR RESEARCHH-index: 202

    CiteScore: 21.50
    Circulation-Arrhythmia and ElectrophysiologyH-index: 87

    CiteScore: 13.70
    EUROPACEH-index: 92

    CiteScore: 10.30
    Circulation-Heart FailureH-index: 88

    CiteScore: 12.90
    BASIC RESEARCH IN CARDIOLOGYH-index: 86

    CiteScore: 16.30
    TRENDS IN CARDIOVASCULAR MEDICINEH-index: 92

    CiteScore: 18.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Cardiology110001
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY105864
    CARDIOVASCULAR RESEARCH104336
    EUROPEAN HEART JOURNAL65368
    HEART57446
    CARDIOLOGY52040
    BASIC RESEARCH IN CARDIOLOGY48201
    AMERICAN JOURNAL OF CARDIOLOGY46517
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY44575
    CLINICAL CARDIOLOGY39743
  •  

    Acta Cardiologica Sinica Acta Cardiologica Sinica
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Acta Cardiologica Sinica] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:26:59 評論於
This varies from person to person. If the main result has been completed, it is generally recommended to start with the results. If the main result is still in progress, you can start with the methods and introduction
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:30:01 評論於
It is recommended to complete the main results section before starting to write the article. You can also start brainstorming the article after obtaining the main phenotype data or designing the topic, and start writing while doing it
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 10:24:26 評論於
What is the general writing order of a research article?
(0) 讚! | 深渊兴业

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:19:44 評論於
At what stage of the experiment is it more appropriate to start writing?
(0) 讚! | 破戒阳平

作者: 天际士航


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-25 16:41:31 評論於
I have also been awaiting EIC decision for a long time, how about your result?
(0) 讚! | 天际士航

作者: 虚徒丰雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-08 12:32:34 評論於
It has been 20 days since my awaiting EIC decision, I wonder if it is good or bad luck ?
(0) 讚! | 虚徒丰雅

作者: 墟散诗雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-03 12:13:56 評論於
Today I received email confirmations from each author, so I should be able to proceed, right? Thank you
(0) 讚! | 墟散诗雯

作者: 墟散诗雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-30 09:52:49 評論於
Does this magazine charge for placement?
(0) 讚! | 墟散诗雯

作者: 墟散诗雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-30 10:32:51 評論於
My submission has always been in the state of "View Submission," what's going on?
(0) 讚! | 墟散诗雯

作者: 不灭和宜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-11 16:11:21 評論於
Review Speed: 2.0 | Acceptance Rate: 50.0 Experience Sharing: The review process was relatively long. The submission was made on October 29, 2018, and the first review was completed on January 2, 2019. A major revision was requested on January 10, with the second review completed on March 10. Minor revisions were requested on March 11, and acceptance was on March 27. Overall, the submission process was quite smooth, the editor was very nice, and the review comments were also very fair
(0) 讚! | 不灭和宜

作者: asdgh


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2018-09-26 16:51:39 評論於
Very good journal.You can try to contribute!
(0) 讚! | asdgh

作者: Yves Morton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-26 08:18:18 評論於
Great magazine. Everyone should give it a try to submit!
(0) 讚! | Yves Morton

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 22:31:16 評論於
As long as we can keep the journal indexed by SCI, it will be fine. If the school starts using CiteScore for evaluation, there is nothing to worry about. On one hand, CiteScore includes a wider range of journals, so this journal will definitely be included. Additionally, it benefits smaller journals as well, so everyone will have a fairer chance. I hope the school adopts CiteScore
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Acta Cardiologica Sinica] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*